This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Formerly CARR Centritech, a brand of Pneumatic Scale Angelus -- one of Barry-Wehmiller’s well-known packaging divisions -- the centrifuge product lines of both stainless steel and single-use separation systems will now operate as an independent business. The new CARR Biosystems company will serve customers in both emerging and established markets, such as cell and gene therapy, vaccine development, biologics, proteins, microbial fermentation, and cellular agriculture.
With almost 30 years of experience delivering versatile, industry-leading products that accelerate process development, CARR Biosystems delivers high-performance, fully-scalable separation solutions from early-stage development to commercial manufacturing.
“Life-saving advances are made possible by robust processes,” said Carol O’Neill, Barry-Wehmiller’s Group President, Packaging, 
Joel Williams, President, CAAR Biosystems.
Joel Williams joins the CARR Biosystems team as President. Williams most recently served as President of the Pharmaceutical and Advanced Technology Business Group of ILC Dover, a leader in single-use technologies for Biotherapeutic applications. A graduate of Harvard Business School, with degrees in Materials Science and Engineering from MIT and Mechanical Engineering from Brigham Young, his technical aptitude and expertise as a business builder position him to lead CARR Biosystems in meeting the growing demand for innovation in biotherapeutic processing.
“I’m excited to help customers discover how CARR Biosystems can increase production yield and viability in their shear-sensitive therapies,” Williams said. “CARR centrifuges accelerate development for life-saving and life-changing treatments by making it easy to scale from development to commercial production.”
